The congress will delve into transformative topics shaping cancer research, including cancer prevention, interception, epigenetics, metastasis, and cancer evolution, offering a deeper understanding of mechanisms driving progression and resistance.

Attendees will explore the impact of artificial intelligence in revolutionising diagnostics, therapeutics, and outcomes, alongside advancements in cancer immunology and the next generation of immunotherapies.

Key themes will include aging and senescence, microbiome insights bridging basic research to clinical applications, and metabolism dysregulation, focusing on therapeutic vulnerabilities in cancer cells to foster innovative treatments.

Organised through a partnership between Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO), and Unicancer, MAP 2025 promises a cutting-edge programme at the forefront of cancer research and care.

Join us in Paris to shape the future of oncology through science, medicine, and innovation.